Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,406 | 22 | 60.1% |
| Food and Beverage | $12,349 | 643 | 14.7% |
| Travel and Lodging | $11,555 | 18 | 13.8% |
| Consulting Fee | $9,450 | 2 | 11.3% |
| Education | $141.49 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $35,405 | 58 | $0 (2024) |
| Genentech USA, Inc. | $31,150 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $9,311 | 125 | $0 (2024) |
| ABBVIE INC. | $1,514 | 106 | $0 (2024) |
| EMD Serono, Inc. | $951.12 | 39 | $0 (2024) |
| Lilly USA, LLC | $438.15 | 24 | $0 (2024) |
| PFIZER INC. | $437.87 | 30 | $0 (2024) |
| Lundbeck LLC | $416.45 | 23 | $0 (2024) |
| Eisai Inc. | $371.06 | 21 | $0 (2024) |
| ARGENX US, INC. | $338.68 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,365 | 170 | EMD Serono, Inc. ($655.92) |
| 2023 | $2,605 | 151 | ABBVIE INC. ($464.20) |
| 2022 | $1,676 | 95 | ABBVIE INC. ($402.18) |
| 2021 | $331.48 | 19 | SK Life Science, Inc. ($86.36) |
| 2020 | $258.14 | 17 | Sunovion Pharmaceuticals Inc. ($108.61) |
| 2019 | $14,050 | 45 | Genentech USA, Inc. ($13,388) |
| 2018 | $25,650 | 97 | Genentech USA, Inc. ($10,506) |
| 2017 | $35,967 | 99 | Biogen, Inc. ($28,358) |
All Payment Transactions
693 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: PAIN | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Immunology | ||||||
| 12/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $202.31 | General |
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $90.00 | General |
| 12/10/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Neurology | ||||||
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $33.94 | General |
| 12/03/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.68 | General |
| 12/03/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.00 | General |
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Neurology | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: PAIN | ||||||
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 369 | 468 | $84,488 | $45,154 |
| 2022 | 5 | 171 | 188 | $37,795 | $19,295 |
| 2021 | 1 | 36 | 57 | $14,649 | $4,797 |
| 2020 | 2 | 45 | 63 | $17,894 | $4,876 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 246 | $37,884 | $21,388 | 56.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $26,680 | $13,396 | 50.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $8,390 | $4,148 | 49.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $7,410 | $3,865 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,424 | $1,332 | 55.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 17 | $1,700 | $1,025 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 84 | $15,308 | $7,481 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $13,038 | $6,819 | 52.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $4,180 | $2,246 | 53.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $3,969 | $2,044 | 51.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $1,300 | $705.25 | 54.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 57 | $14,649 | $4,797 | 32.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 51 | $13,238 | $3,681 | 27.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $4,656 | $1,195 | 25.7% |
About Dr. Laura Minto, MD
Dr. Laura Minto, MD is a Neurology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386791259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Minto, MD has received a total of $83,902 in payments from pharmaceutical and medical device companies, with $3,365 received in 2024. These payments were reported across 693 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,406).
As a Medicare-enrolled provider, Minto has provided services to 621 Medicare beneficiaries, totaling 776 services with total Medicare billing of $74,123. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Mobile, AL
- Active Since 01/04/2007
- Last Updated 02/22/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386791259
Products in Payments
- OCREVUS (Biological) $24,133
- TECFIDERA (Drug) $20,006
- GILENYA (Drug) $8,226
- Non-Covered Product (Drug) $6,604
- ZINBRYTA (Biological) $6,007
- TYSABRI (Biological) $5,932
- KESIMPTA (Drug) $686.98
- QULIPTA (Drug) $625.58
- BOTOX (Biological) $589.92
- NURTEC ODT (Drug) $452.73
- Ocrevus (Biological) $407.16
- ZEPOSIA (Drug) $340.24
- APTIOM (Drug) $320.65
- Leqembi (Drug) $305.75
- UBRELVY (Drug) $304.13
- VYVGART (Drug) $293.47
- NUPLAZID (Drug) $290.22
- VYEPTI (Biological) $288.74
- AMYVID (Drug) $279.88
- LEMTRADA (Drug) $212.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Mobile
Dr. Daniel Dees, M.d, M.D
Neurology — Payments: $803,515
Dr. Hayden Long, Md, MD
Neurology — Payments: $295,347
Dr. Charles Markle, M.d, M.D
Neurology — Payments: $265,994
Dean Naritoku, M.d, M.D
Neurology — Payments: $250,962
Bassam Bassam, Md, MD
Neurology — Payments: $139,121
Dr. Juan Ochoa, Md, MD
Neurology — Payments: $88,415